Protocol Ledger

NCT06936943 · Phase II · RECRUITING

ONO-4538 Study in Patients With Richter's Transformation

Interventional Phase II clinical trial protocol NCT06936943 sponsored by Ono Pharmaceutical Co in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-11-19 Enrollment: 14 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06936943
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)14 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06936943
Protocol FieldVerified Registry Value
NCT IdentifierNCT06936943
Consolidated Lead SponsorOno Pharmaceutical Co
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment14 participants (ESTIMATED)
Registered Start Date2025-11-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06936943
Hospital Research SiteLocationSite Profile
Hokkaido University HospitalSapporo, JapanOpen Hospital Dossier ->
Kyoto University HospitalKyoto, JapanOpen Hospital Dossier ->
Tohoku University HospitalSendai, JapanOpen Hospital Dossier ->
National Cancer Center HospitalChuo-ku, JapanOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI